Clinical trial
An Open-Label, Randomized, Fasting, Single-Dose, Two-Sequence, Two-Period Crossover Study to Evaluate the Bioequivalence of "AJU-C715" and "C715R" in Healthy Adult Volunteers
NCT07581028 is registered in ClinicalTrials.gov with AJU Pharm Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label, Randomized, Fasting, Single-Dose, Two-Sequence, Two-Period Crossover Study to Evaluate the Bioequivalence of "AJU-C715" and "C715R" in Healthy Adult Volunteers
- Lead sponsor
- AJU Pharm Co., Ltd.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- August 6, 2026
- Completion date
- August 28, 2026
- Enrollment
- 61 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dyslipidemia, hypercholerolemia